Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2013-03-01
Schriftenreihe:Frontiers in Oncology
Schlagworte:
p53
tumor suppressor
Glioblastoma Multiforme
WWOX
temozolomide resistance
Online Zugang:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge